Development and evaluation of polymer nanoparticles for oral delivery of estradiol to rat brain in a model of Alzheimer's pathology.

No abstract is available for this paper.

• Publication year

  2011

• Venue

  Journal of Controlled Release

• Publication date

  2011-03-10

• Fields of study

  Medicine, Materials Science, Chemistry

• Identifiers
  DOI 10.1016/j.jconrel.2010.11.013PMID 21111014
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Nanoparticle interaction with plasma proteins as it relates to particle biodistribution, biocompatibility and therapeutic efficacy.

  2009cited by this paper
• Alzheimer's disease in women.

  2009cited by this paper
• Non-genomic actions of estrogens and their interaction with genomic actions in the brain.

  2008cited by this paper
• More than a decade of estrogen neuroprotection

  2008cited by this paper
• Pathological and biochemical alterations of astrocytes in ovariectomized rats injected with D-galactose: a potential contribution to Alzheimer's disease processes.

  2008cited by this paper
• Intracellular amyloid-beta in Alzheimer's disease.

  2007cited by this paper
• Long-term D-galactose injection combined with ovariectomy serves as a new rodent model for Alzheimer's disease.

  2007cited by this paper
• Intracellular amyloid-β in Alzheimer's disease

  2007cited by this paper
• Intraneuronal β-Amyloid Aggregates, Neurodegeneration, and Neuron Loss in Transgenic Mice with Five Familial Alzheimer's Disease Mutations: Potential Factors in Amyloid Plaque Formation

  2006cited by this paper
• Opsonization, biodistribution, and pharmacokinetics of polymeric nanoparticles.

  2006cited by this paper
• Design of Estradiol Loaded PLGA Nanoparticulate Formulations: A Potential Oral Delivery System for Hormone Therapy

  2006cited by this paper
• Brain-targeted delivery of estradiol

  2006cited by this paper
• A dynamic relationship between intracellular and extracellular pools of Abeta.

  2006cited by this paper
• Double-coated poly (butylcynanoacrylate) nanoparticulate delivery systems for brain targeting of dalargin via oral administration.

  2005cited by this paper
• Application of nanoparticles for the delivery of drugs to the brain

  2005cited by this paper
• Antinociceptive effects of elevated plus-maze exposure: influence of opiate receptor manipulations

  2005cited by this paper
• A modified β‐amyloid hypothesis: intraneuronal accumulation of the β‐amyloid peptide – the first step of a fatal cascade

  2004cited by this paper
• Bioabsorbable implant material review

  2004cited by this paper
• Specific role of polysorbate 80 coating on the targeting of nanoparticles to the brain.

  2004cited by this paper
• Alzheimer's disease.

  2004cited by this paper
• Nanoparticulate systems for brain delivery of drugs.

  2001cited by this paper
• The origins of Alzheimer disease: a is for amyloid.

  2000cited by this paper
• Intraneuronal Abeta42 accumulation in human brain.

  2000cited by this paper
• Intraneuronal Aβ42 Accumulation in Human Brain

  2000cited by this paper
• Indirect Evidence that Drug Brain Targeting Using Polysorbate 80-Coated Polybutylcyanoacrylate Nanoparticles Is Related to Toxicity

  1999cited by this paper
• Can estrogen keep you smart? Evidence from clinical studies.

  1999cited by this paper
• Efficacy of oral dalargin-loaded nanoparticle delivery across the blood-brain barrier.

  1998cited by this paper
• Influence of the type of surfactant on the analgesic effects induced by the peptide dalargin after its delivery across the blood–brain barrier using surfactant-coated nanoparticles

  1997cited by this paper
• Long-term estrogen replacement therapy in female patients with dementia of the Alzheimer type: 7 case reports.

  1995cited by this paper
• Alkylcyanoacrylate drug carriers: II. Cytotoxicity of cyanoacrylate nanoparticles with different alkyl chain length

  1992cited by this paper
• An immunohistochemical quantification of fibrous astrocytes in the aging human cerebral cortex.

  1987cited by this paper
• Validation of open:closed arm entries in an elevated plus-maze as a measure of anxiety in the rat.

  1985cited by this paper
• Early onset and topographical distribution of hypertrophied astrocytes in hippocampus of aging rats: a quantitative study.

  1979cited by this paper
• The absorptiometric determination of polyethyleneglycol mono-oleate

  1955cited by this paper

• “Therapies Through Gut:” Targeted Drug Delivery for Non‐Gastrointestinal Diseases by Oral Administration

  2025cites this paper
• Nanomedicines and stroke: Advantages in chronic inflammation treatment and neural regeneration.

  2025cites this paper
• Nanoscale drug formulations for the treatment of Alzheimer's disease progression

  2025cites this paper
• Development of Sesamol Loaded-Polymer-Lipid Blend Nanoparticles: Statistical Optimization, In-Vitro, and Preclinical Assessment

  2025cites this paper
• Native PEG-PLGA Attenuates β-Amyloid Aggregation and Toxicity under In Vitro Conditions.

  2025cites this paper
• Isorhamnetin-lignin nanoparticles: green preparation, characterization, remarkable bioavailability and long-lasting bioactivity in vivo

  2025cites this paper
• REVOLUTIONIZING ALZHEIMER’S THERAPEUTICS: FROM MICROTECHNOLOGIES TO AI-DRIVEN INNOVATIONS

  2025cites this paper
• Nanoparticles in CNS Therapeutics: Pioneering Drug Delivery Advancements.

  2024cites this paper
• Nanotechnology in the diagnostic and therapy for Alzheimer's disease.

  2024cites this paper
• An Overview of Various Approaches for Brain Targeted Drug Delivery System

  2024cites this paper
• QbD-based Optimization and Evaluation of Chitosan-Adorned Nanostructured Lipid Carriers for Nose-to-Brain Delivery of 17β-Estradiol in Rat Model of Alzheimer's Disease

  2024cites this paper
• Development of Nanomedicines for the Treatment of Alzheimer's Disease: Raison d'être, Strategies, Challenges and Regulatory Aspects.

  2024cites this paper
• Unveiling the toxicity of micro-nanoplastics: A systematic exploration of understanding environmental and health implications

  2024cites this paper
• Nanotechnology-Based Drug Delivery For Alzheimer's And Parkinson's Diseases.

  2023cites this paper
• Mesenchymal and Neural Stem Cell-Derived Exosomes in Treating Alzheimer’s Disease

  2023cites this paper
• Folic acid-modified reverse micelle-lipid nanocapsules overcome intestinal barriers and improve the oral delivery of peptides

  2023influential citation
• Tailor-made nanocargoes as promising tool for brain targeting: Modulated approaches with better therapeutic outcomes

  2023cites this paper
• Intranasal Drug Delivery by Nanotechnology: Advances in and Challenges for Alzheimer’s Disease Management

  2023cites this paper
• Polymeric nanotherapeutics: An emerging therapeutic approach for the management of neurodegenerative disorders

  2023cites this paper
• ApoE—functionalization of nanoparticles for targeted brain delivery—a feasible method for polyplexes?

  2023cites this paper
• Biopolymers as promising vehicles for drug delivery to the brain

  2023cites this paper
• Applications of Nanoparticles in Alzheimer’s Disease

  2023cites this paper
• Oral Nanomedicine: Challenges and Opportunities

  2023cites this paper
• Basic Concepts, Hypotheses and Drug Development of Alzheimer's Disease

  2023cites this paper
• Recent Advancements in Nanomaterials: A Promising Way to Manage Neurodegenerative Disorders

  2023cites this paper
• Therapeutic nanotechnologies for Alzheimer's disease: a critical analysis of recent trends and findings.

  2022cites this paper
• Oral delivery of polyester nanoparticles for brain-targeting: Challenges and opportunities

  2022cites this paper
• Native PLGA nanoparticles regulate APP metabolism and protect neurons against β-amyloid toxicity: Potential significance in Alzheimer's disease pathology.

  2022cites this paper
• Nanoparticles in Combating Neuronal Dysregulated Signaling Pathways: Recent Approaches to the Nanoformulations of Phytochemicals and Synthetic Drugs Against Neurodegenerative Diseases

  2022cites this paper
• Role of Nanotechnology and Their Perspectives in the Treatment of Kidney Diseases

  2022cites this paper
• Biopolymer Nanoparticles for Nose-to-Brain Drug Delivery: A New Promising Approach for the Treatment of Neurological Diseases

  2022cites this paper
• Box Behnken Design Optimized Silibinin Loaded Glycerylmonooleate Nanoliquid Crystal for Brain Targeting.

  2022cites this paper
• Surface functionalization of PLGA nanoparticles for potential oral vaccine delivery targeting intestinal immune cells.

  2022cites this paper
• Brain Drug Delivery and Neurodegenerative Diseases: Polymeric PLGA-Based Nanoparticles as a Forefront Platform.

  2022cites this paper
• Nanotherapeutics and the Brain.

  2022cites this paper
• Recent Trend of Nano-Particulate Carriers for the Diagnosis and Treatment of Alzheimer's disease.

  2022cites this paper
• Alzheimer's disease and its treatment by different approaches: A review.

  2021cites this paper
• Nanotechnology-based drug delivery for central nervous system disorders.

  2021cites this paper
• Effective Antitumor of Orally Intestinal Targeting Penetrating Peptide-Loaded Tyroserleutide/PLGA Nanoparticles in Hepatocellular Carcinoma

  2021cites this paper
• KATI LİPİT NANOPARTİKÜLLER VE BEYNE ÖZGÜ İLAÇ TAŞIYICI SİSTEM OLARAK UYGULAMALARI

  2021cites this paper
• Development of Polymeric Nanoparticles for Blood–Brain Barrier Transfer—Strategies and Challenges

  2021cites this paper
• Intestinal Mucosal Models to Validate Functionalized Nanosystems

  2021cites this paper
• Therapeutic Strategies and Nano-Drug Delivery Applications in Management of Aging Alzheimer's Disease.

  2021cites this paper
• Surfactants influence polymer nanoparticle fate within the brain.

  2021cites this paper
• Bio-nano Interface and Its Potential Application in Alzheimer’s Disease

  2021cites this paper
• A Meta-Analysis Study on Alzheimer’s Disease

  2021cites this paper
• Engineered exosomes: desirable target-tracking characteristics for cerebrovascular and neurodegenerative disease therapies

  2021cites this paper
• Novel Oral Drug Delivery Systems for Steroids: Overview and Recent Updates

  2020cites this paper
• Biodegradable Polymeric Nanoparticles for Brain-Targeted Drug Delivery

  2020cites this paper
• A review on designing Poly (lactic-co-glycolic acid) nanoparticles as drug delivery systems.

  2020cites this paper
• Poly(lactic-co-glycolic Acid) Nanoparticle Encapsulated 17β-Estradiol Improves Spatial Memory and Increases Uterine Stimulation in Middle-Aged Ovariectomized Rats

  2020cites this paper
• Multifunctional Polymeric Nanoplatforms for Brain Diseases Diagnosis, Therapy and Theranostics

  2020cites this paper
• Highly Stabilized Nanocrystals Delivering Ginkgolide B in Protecting against the Parkinson's Disease.

  2020cites this paper
• Neuroprotective Effect of New Nanochelating-Based Nano Complex, ALZc3, Against Aβ (1–42)-Induced Toxicity in Rat: a Comparison with Memantine

  2020cites this paper
• Neurotherapeutic applications of nanomedicine for treating Alzheimer's disease.

  2020cites this paper
• Advances in Tissue Engineering and Innovative Fabrication Techniques for 3-D-Structures: Translational Applications in Neurodegenerative Diseases

  2020cites this paper
• Nanomedicine against Alzheimer's and Parkinson's disease.

  2020cites this paper
• From Adsorption to Covalent Bonding: Apolipoprotein E Functionalization of Polymeric Nanoparticles for Drug Delivery Across the Blood–Brain Barrier

  2020cites this paper
• Nanotherapeutic strategies for the treatment of neurodegenerative diseases

  2019cites this paper
• Nanomedicine in Alzheimer's disease: Amyloid beta targeting strategy.

  2019cites this paper
• Nanopharmaceuticals: A Boon to the Brain-Targeted Drug Delivery

  2019cites this paper
• Design and Biological Evaluation of Lipoprotein-Based Donepezil Nanocarrier for Enhanced Brain Uptake through Oral Delivery.

  2019cites this paper
• Nanoparticle-mediated approaches for Alzheimer's disease pathogenesis, diagnosis, and therapeutics.

  2019cites this paper
• Alzheimer's Disease Targeted Nano-Based Drug Delivery Systems.

  2019cites this paper
• Neuro-protective role of nanocapsulated curcumin against cerebral ischemia-reperfusion induced oxidative injury.

  2019cites this paper
• Drug targeting strategies into the brain for treating neurological diseases.

  2019cites this paper
• A window into the brain: Tools to assess pre-clinical efficacy of biomaterials-based therapies on central nervous system disorders.

  2019cites this paper
• Asenapine maleate-loaded nanostructured lipid carriers: optimization and in vitro, ex vivo and in vivo evaluations.

  2019cites this paper
• Optimizing the Delivery of 17β-estradiol: Maximizing Beneficial Cognitive Effects While Minimizing Undesired Peripheral Stimulation in a Rat Model of Surgical Menopause

  2018cites this paper
• Design of epigallocatechin gallate loaded PLGA/PF127 nanoparticles and their effect upon an oxidative stress model

  2018cites this paper
• Neurobehavioral assessment of rats exposed to pristine polystyrene nanoplastics upon oral exposure.

  2018cites this paper
• Monoolein‐based nanoparticles for drug delivery to the central nervous system: A platform for lysosomal storage disorder treatment

  2018cites this paper
• Treatment of neurodegenerative disorders through the blood-brain barrier using nanocarriers.

  2018cites this paper
• Ligand-cascading nano-delivery devices to enable multiscale targeting of anti-neurodegenerative therapeutics

  2018cites this paper
• Targeted Nanoparticles for the Treatment of Alzheimer's Disease.

  2017cites this paper
• Drug Delivery to the Brain across the Blood-Brain Barrier Using Nanomaterials.

  2017cites this paper
• Surface modified nano-lipid drug conjugates of positive allosteric modulators of M1 muscarinic acetylcholine receptor for the treatment of Alzheimer's disease.

  2017cites this paper
• Biodegradable polymeric nanostructures: design and advances in oral drug delivery for neurodegenerative disorders

  2017cites this paper
• Nanotechnology Based Theranostic Approaches in Alzheimer's Disease Management: Current Status and Future Perspective.

  2017cites this paper
• Engineering poly(lactic-co-glycolic acid) (PLGA) micro- and nano-carriers for Controlled Delivery of 17β-Estradiol

  2017cites this paper
• Preparation of poly(lactic-co-glycolic acid) and chitosan composite nanocarriers via electrostatic self assembly for oral delivery of insulin.

  2017cites this paper
• Recent applications of PLGA based nanostructures in drug delivery.

  2017cites this paper
• Nanovectors for Neurotherapeutic Delivery Part II: Polymeric Nanoparticles

  2017cites this paper
• Prunella vulgaris L., an Edible and Medicinal Plant, Attenuates Scopolamine-Induced Memory Impairment in Rats.

  2017cites this paper
• Targeted nano-carriers to combat neurodegeneration

  2017cites this paper
• A critical overview of therapeutic strategy and advancement for Alzheimer's disease treatment

  2017cites this paper
• Morphologies and functionalities of polymeric nanocarriers as chemical tools for drug delivery: A review

  2017cites this paper
• Deciphering the mechanism and structural features of polysorbate 80 during adsorption on PLGA nanoparticles by attenuated total reflectance – Fourier transform infrared spectroscopy

  2016cites this paper
• Bio-inspired nano tools for neuroscience.

  2016cites this paper
• Potential Nanocarriers for Brain Drug Delivery

  2016cites this paper
• Application of Nanomedicine to the CNS Diseases.

  2016cites this paper
• Developments in Methods for Measuring the Intestinal Absorption of Nanoparticle-Bound Drugs

  2016cites this paper
• Formulation, optimization, and pharmacodynamic evaluation of chitosan/phospholipid/β-cyclodextrin microspheres

  2016cites this paper
• Improving drug delivery technology for treating neurodegenerative diseases

  2016cites this paper
• Nanomaterials for Neurology: State-of-the-Art.

  2016cites this paper
• Nano(Neuro)Medicinal Interventions for Neurodegenerative 284 Disorders: A Meta-Analysis of Concurrent Challenges and Strategic Solutions

  2016cites this paper
• Nanotherapeutic strategies for the treatment of Alzheimer's disease.

  2015cites this paper
• Nanomaterials and neurodegeneration

  2015cites this paper
• Novel PLGA-based nanoparticles for the oral delivery of insulin

  2015cites this paper
• Ovarian hormones ameliorate memory impairment, cholinergic deficit, neuronal apoptosis and astrogliosis in a rat model of Alzheimer's disease

  2015cites this paper